William Hinson to Combined Modality Therapy
This is a "connection" page, showing publications William Hinson has written about Combined Modality Therapy.
Connection Strength
0.106
-
Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. 2015 Aug 07; 6(22):18945-55.
Score: 0.030
-
Kilburn JM, Lester SC, Lucas JT, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer. J Thorac Oncol. 2014 Apr; 9(4):572-6.
Score: 0.027
-
Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, Oaks T, Miller AA, Blackstock AW. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer. J Thorac Oncol. 2010 Jan; 5(1):69-74.
Score: 0.020
-
Blackstock AW, Ho C, Butler J, Fletcher-Steede J, Case LD, Hinson W, Miller AA. Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer. J Thorac Oncol. 2006 Jun; 1(5):434-40.
Score: 0.016
-
Ekstrand KE, Hinson WH, Bourland JD, deGuzman AF, Stieber VW, Tatter SB, Ellis TL. The use of a Leksell-BRW adapter for linac radiosurgery as an adjunct to Gamma Knife treatment. Phys Med Biol. 2003 Dec 21; 48(24):4105-10.
Score: 0.013